Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Exclusive UK Partnership

25th Jan 2007 07:02

Fisher (James) & Sons PLC25 January 2007 For release 7am Thursday 25 January 2007 James Fisher Announce Exclusive UK Partnership with Synodys Group James Fisher IMS, a subsidiary of James Fisher and Sons plc, the marine andengineering services business, announce a strategic partnership with the SynodysGroup, the global instruments and monitoring systems company. James Fisher IMS provides inspection and measurement capability to the nuclear,homeland security, defence and aerospace industries. The Synodys Health PhysicsDivision provides active dosimetry, passive dosimetry, and contamination andclearance systems as services to nuclear, military and civil defence, andmedical markets. The division is headquartered in Lamanon, France, and sellsunder the Synodys, MGP, and Rados brands. The partnership provides James Fisher IMS, which has a strong UK presence andexcellent reputation, with a comprehensive portfolio of radiation measurementsystems to satisfy its customer requirements. The UK market focus, commitmentand resources that Fisher brings to the partnership represent a major stepforward for Synodys in the UK. James Fisher IMS is now the exclusive partner for UK sales, support and service.The UK customer base is of major importance to Synodys and this partnershipsupports the goal of enhancing coverage, technical support and services to ourcustomers. Paul Read, Managing Director, James Fisher IMS, comments: "The partnership with Synodys is an important element in our strategy ofproviding the customer base with a comprehensive product and service portfolioin all markets were quality, responsiveness and value are key to our customers." Antony Besso, CEO, Synodys Health Physics, said: "James Fishers commitment to the UK customer base, coverage and complimentarycapabilities make it an ideal partner for both products and services." - ENDS - For more information contact: James Fisher IMSwww.james-fisher.co.ukPaul Read, Managing Director [email protected] 0161 232 1414 Synodys Steve Phillips [email protected] +33 (0)490 595 959 Adventis Financial PR Peter Binns [email protected] 020 7034 4760 This information is provided by RNS The company news service from the London Stock Exchange

Related Shares:

James Fisher and Sons
FTSE 100 Latest
Value8,275.66
Change0.00